Nucleic acid polymers prevent the establishment of duck hepatitis B virus infection in vivo.
about
Hepatitis B virus infection: An insight into infection outcomes and recent treatment optionsTherapeutic Strategies and New Intervention Points in Chronic Hepatitis Delta Virus InfectionInhibition of hepatitis B viral entry by nucleic acid polymers in HepaRG cells and primary human hepatocytesAnimal models and the molecular biology of hepadnavirus infectionTherapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection.Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B InfectionTreatment of hepatitis B virus: an update.Hepatitis Delta Virus: Replication Strategy and Upcoming Therapeutic Options for a Neglected Human Pathogen.Transbody against virus core protein potently inhibits hepadnavirus replication in vivo: evidence from a duck model of hepatitis B virus.Nucleic acid-based polymers effective against hepatitis B Virus infection in patients don't harbor immunostimulatory properties in primary isolated liver cells.Recent advances in managing hepatitis DOligonucleotides designed to inhibit TLR9 block Herpes simplex virus type 1 infection at multiple steps.Nucleic Acid Polymers with Accelerated Plasma and Tissue Clearance for Chronic Hepatitis B Therapy.Nucleic acid polymers inhibit duck hepatitis B virus infection in vitro.Nucleic acid polymers are active against Hepatitis Delta Virus infection in vitro.Activity of nucleic acid polymers in rodent models of HBV infection.Drugs in Development for Hepatitis B.
P2860
Q26782127-352B880D-3636-42D3-9B1D-689B32F618BBQ26795919-B34E2087-9BDA-411C-985F-5E7DC1EF2229Q33821878-15B27D32-BF19-4C93-BFD9-655609D51693Q35245221-39387F19-F6B4-4C28-9BD7-13FEB6B008FAQ35839139-4D0373E4-0402-410A-966F-DD19A8FCD3BDQ36039553-E2EF9915-0523-487E-A10F-EBDA35EE18E6Q38794446-BE74FF1B-5BAA-4472-8983-D00B16ADC400Q39414876-A761BAD0-6AAA-4A5A-9D04-C9C026D19C70Q40255481-E6AB5BF6-6FEB-441A-BEDE-5535D7EBF3B9Q40302798-6BE8041C-589E-4035-A753-C99AF238646FQ41588940-BE19483D-28FA-4695-960B-6F2A2A6CA25EQ42207445-56FF4913-7920-4F98-93EB-199572C6E876Q42209643-F7F47462-9343-4F80-B51C-5D51E3A930B9Q42277109-E6F3B4A2-DCE9-419B-9113-B6B20CB13418Q45323707-579B8E9F-1546-43FA-897D-04AE1517B7DEQ46263692-F526852F-D363-4A43-82BD-DBFB9CD4DB33Q52764230-3F484507-014A-46DE-87A5-FA6B01448A69
P2860
Nucleic acid polymers prevent the establishment of duck hepatitis B virus infection in vivo.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Nucleic acid polymers prevent ...... tis B virus infection in vivo.
@en
Nucleic acid polymers prevent ...... tis B virus infection in vivo.
@nl
type
label
Nucleic acid polymers prevent ...... tis B virus infection in vivo.
@en
Nucleic acid polymers prevent ...... tis B virus infection in vivo.
@nl
prefLabel
Nucleic acid polymers prevent ...... tis B virus infection in vivo.
@en
Nucleic acid polymers prevent ...... tis B virus infection in vivo.
@nl
P2093
P2860
P356
P1476
Nucleic acid polymers prevent ...... tis B virus infection in vivo.
@en
P2093
Allison R Jilbert
Andrew Vaillant
Faseeha Noordeen
P2860
P304
P356
10.1128/AAC.01005-13
P407
P577
2013-08-12T00:00:00Z